--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Chromatic Glass" developer_entity: "Kazunori Asada" bundle_id: "com.k-asada.CBTool" app_store_id: "388924058" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2022-09-24" report_date: "2026-08-29" last_verified: "2026-08-29T00:00:00.000Z" report_version: "2.21" total_reviews: 2 overall_rating: 5 confidence: "low" confidence_score: 0.2 data_age_days: 43 momentum_velocity: "zombie" intelligence_version: 3 tags: ["medical", "free", "mobile app", "app review", "app analysis", "individuals", "congenital", "acquired"] canonical_url: "https://marlvel.ai/apps/chromatic-glass" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Chromatic Glass Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 5 > **TL;DR:** Chromatic Glass is a medical app by Kazunori Asada, rated 5/5 by 2 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Chromatic Glass is a medical app by Kazunori Asada. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 5/5 (2 reviews) | | **Category** | Medical | | **Developer** | Kazunori Asada | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.2/1.0) | | **Data Age** | 43d | ## Metadata & Market Performance - **Publisher:** Kazunori Asada - **Category:** Medical - **Target Audience:** Individuals with congenital or acquired color vision deficiency seeking assistance in distinguishing colors. - **Platforms:** iOS - **Version Reviewed:** 2.21 - **Report Date:** 2026-08-29 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.2/1.0) - **App Store ID (iOS):** 388924058 - **Bundle ID:** com.k-asada.CBTool - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-29 ## Executive Snapshot **What it is:** Chromatic Glass is a medical accessibility tool that applies real-time color-correction algorithms to camera feeds for users with color vision deficiency. **Why users hire it:** The app removes the cognitive friction of distinguishing colors in real-time, serving users who struggle with Protan, Deutan, or Tritan conditions. ## App DNA (Features & Intent) - **[Differentiator] Real-time Color Modification:** Applies scientific color-correction algorithms to camera input in real-time to assist color vision deficiency users - **[Differentiator] Split-view Comparison:** Displays the original camera feed alongside the modified color-corrected image for immediate visual comparison - **[Standard] Type-specific Correction:** Supports correction profiles for Protan, Deutan, and Tritan color vision deficiency types * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Chromatic Glass operates as a specialized medical utility with no active chart presence. The 1,435-day update gap confirms its status as a legacy tool rather than a competitive market participant. ## Monetization Strategy - **Model:** Free - **Tiers:** Fully free application - **Analysis:** The app is distributed as a free tool with no identified monetization gates or subscription tiers. ## SWOT Analysis {#swot} **Core Strengths:** - Scientific color-correction algorithms provide specialized utility for color-vision deficiency **Growth Levers:** - Modernizing the interface could capture users seeking updated accessibility tools ## Recent Changes (v2 → v3) {#recent-changes} The competitive outlook for Chromatic Glass has transitioned from stable to declining, as the lack of development is now explicitly linked to potential compatibility failures on modern iOS hardware. **Overall trend**: Declining **Compared at**: 2026-08-29 ### High-impact changes - **[Shifted] Market status reclassification** (positioning) ### Medium-impact changes - **[Added] Compatibility risk identification** (swot) - **[Declined] Outlook trend downgrade** (sentiment) ## What's New - **Latest (v2.21, 3 years ago):** Resolved an issue causing incorrect camera image rotation in landscape mode on iOS 16. ## App Momentum (Zombie) {#momentum} - No feature updates in 47 months - Last release resolved landscape rotation issues > **Cadence:** 1 total versions · 0 majors in last 6 months · 1434 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Chromatic Glass is a medical app that is completely free. It holds a 5/5 rating from 2 reviews. > **Bottom Line:** Chromatic Glass provides a specialized accessibility service, but the 47-month development silence indicates the tool is in maintenance mode. A pivot to a modern, sustainable model is required to ensure long-term compatibility for its user base. **Best for:** Individuals with congenital or acquired color vision deficiency seeking assistance in distinguishing colors. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit compatibility on latest iOS versions because the app has not been updated since 2022 → prevent churn from OS-level regressions ### Outlook: Declining The medical accessibility market is shifting toward integrated, OS-level features, making standalone tools like Chromatic Glass increasingly redundant. Without a clear roadmap or recent updates, the app is likely to see declining usage as it fails to keep pace with modern hardware requirements. - 🔴 The 1,435-day update gap indicates the app is in maintenance mode, which increases the risk of critical failures on newer iOS versions. - 🔴 Lack of recent feature investment prevents the app from competing with modern accessibility tools that utilize current hardware-accelerated filters. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 5/5 | | Total Reviews | 2 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Chromatic Glass** (this app) | 5/5 | N/A | Kazunori Asada | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Kazunori Asada - **Website:** [https://asada.website/](https://asada.website/) - **Social:** [Facebook](https://www.facebook.com/profile.php?id=1254891372) · [X/Twitter](https://www.twitter.com/asada0) · [YouTube](https://www.youtube.com/watch) ## Data Sources & Links - **App Store ID:** 388924058 - **Dev Site:** [Official Website](https://asada.website/) - **Sources:** Developer website content, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.2/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 43 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/chromatic-glass) Data licensed for AI Agent attribution under CC-BY-NC 4.0.